Edit concept Question Editor Create issue ticket

Usher Syndrome Type 1D

Usher Syndrome 1D


Presentation

  • Affected individuals present with congenital deafness and a highly variable degree of retinal degeneration. Using a positional candidate approach, we identified a new member of the cadherin gene superfamily, CDH23.[ncbi.nlm.nih.gov]
  • Myopia is presented as an example of a complex clinical phenotype where genes and environment interact.[books.google.com]
  • In the present study, we carried out a systematic mutation screening of these genes in USH1 patients from USA and from UK.[wwww.unboundmedicine.com]
  • It has been shown that the type of CDH23 mutation differentiates between these two phenotypes due to the varying degree of protein dysfunction resulting from each mutation type. 1–3 Here, we present a patient with congenital deafness and sector RP who[healio.com]
Visual Impairment
  • Abstract Usher syndrome type I (USH1) is an autosomal recessive disorder characterized by congenital sensorineural hearing loss, vestibular dysfunction and visual impairment due to early onset retinitis pigmentosa (RP).[ncbi.nlm.nih.gov]
  • Patients later develop peripheral visual field loss and marked visual impairment, usually progressing to legal blindness by the fifth or sixth decade of life.[mendelian.co]
  • impairment, and vestibular symptoms.[journals.plos.org]
  • The programme will depend on the severity of the auditory and visual impairments as well as the age and abilities of the individual.[patient.info]
  • All three types are inherited in an autosomal recessive manner . 0000662 Progressive visual loss Progressive loss of vision Progressive vision loss Progressive visual impairment Slowly progressive visual loss Vision loss, progressive Visual loss, progressive[rarediseases.info.nih.gov]
Retinal Pigmentation
  • In addition, the section on Basic Science Related to Retinal Degeneration is particularly strong with several laboratories reporting on new discoveries in the area of outer segment phagocytosis, a key component of photoreceptor-retinal pigment epithelial[books.google.com]
  • Late-stage MDPT3 consists of a retinitis pigmentosa (RP; see {268000})-like phenotype due to death of retinal pigment epithelium (RPE) and photoreceptor cells.[mendelian.co]
  • […] dystrophy due to retinol transport defect Reticular dystrophy of the retinal pigment epithelium Retinal degeneration-nanophthalmos-glaucoma syndrome Retinal dystrophy Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies Retinal[se-atlas.de]
  • Retinal Transplants & Implants Retinal cell transplantation studies in animals suggest that transplanting retinal pigment epithelial cells may slow or halt the progression of RP.[retinafoundation.org]
Hearing Impairment
  • Usher syndrome (USH) is a group of autosomal recessive sensory disorders characterized by progressive retinitis pigmentosa (RP) and sensorineural hearing impairment.[ncbi.nlm.nih.gov]
  • Willems CRC Press , ١٧‏/١٠‏/٢٠٠٣ - 406 من الصفحات Heredity, either alone or in combination with environmental factors, is the most prominent underlying cause of hearing impairment.[books.google.com]
  • Products Conditions Hearing impairment Usher syndrome CDH23 - Usher syndrome type 1D Turnaround time Complete analysis: 8 weeks / Targeted analysis: 4 weeks Performing laboratory Radboudumc CLRN1 - Usher syndrome type 3A (USH3A) Turnaround time Complete[order.radboudumc.nl]
Hearing Impairment
  • Usher syndrome (USH) is a group of autosomal recessive sensory disorders characterized by progressive retinitis pigmentosa (RP) and sensorineural hearing impairment.[ncbi.nlm.nih.gov]
  • Willems CRC Press , ١٧‏/١٠‏/٢٠٠٣ - 406 من الصفحات Heredity, either alone or in combination with environmental factors, is the most prominent underlying cause of hearing impairment.[books.google.com]
  • Products Conditions Hearing impairment Usher syndrome CDH23 - Usher syndrome type 1D Turnaround time Complete analysis: 8 weeks / Targeted analysis: 4 weeks Performing laboratory Radboudumc CLRN1 - Usher syndrome type 3A (USH3A) Turnaround time Complete[order.radboudumc.nl]
Profound Congenital Hearing Loss
  • Cochlear implants, unilateral or bilateral, are now more frequently used for patients with profound congenital hearing loss. Both cochlear implants and hearing aids are more effective when implemented early.[orpha.net]
Suggestibility
  • Haplotype analysis by SNPs within CDH23 suggests common ancestors for each of the mutations. Among the total of 52 USH1 cases studied by us, CDH23 mutations account for about 10% of all disease alleles.[ncbi.nlm.nih.gov]
  • ., 1997, Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. Am. J. ‏[books.google.com]
Learning Difficulties
  • Symptoms - Usher syndrome- type 1D Night blindness Decreased visual acuity Constricted visual fields Learning difficulties Visual difficulties Causes - Usher syndrome- type 1D Not supplied. Prevention - Usher syndrome- type 1D Not supplied.[checkorphan.org]
Seizure
  • Gene OMIM (Gene) Associated diseases (OMIM) Inheritance CentoMD exclusive variant numbers ( ) ADGRV1 602851 Febrile seizures, familial, 4; Usher syndrome type 2C AD, AR 36 CDH23 605516 Usher syndrome type 1D; deafness type 12; susceptibility to pituitary[centogene.com]

Treatment

  • Put the very latest scientific and genetic discoveries, diagnostic imaging methods, drug therapies, treatment recommendations, and surgical techniques to work in your practice.[books.google.com]
  • Treatment - Usher syndrome- type 1D Not supplied. Resources - Usher syndrome- type 1D Not supplied.[checkorphan.org]
  • There are currently no approved treatments available for Usher syndrome type 1B. UshStat has received European and US Orphan Drug Designation which brings development, regulatory and commercial benefits.[news-medical.net]
  • To date, there are no approved treatments for XLRS.[retinafoundation.org]
  • Research using mouse models will help determine the function of Usher genes and inform potential treatments.[nidcd.nih.gov]

Prognosis

  • Prognosis - Usher syndrome- type 1D Not supplied. Treatment - Usher syndrome- type 1D Not supplied. Resources - Usher syndrome- type 1D Not supplied.[checkorphan.org]
  • Prognosis The prognosis mainly depends on the progression of the visual loss: blindness occurs in almost all cases between 50 and 70 years of age. The documents contained in this web site are presented for information purposes only.[orpha.net]
  • Overall, the patient's genotype appears to confer better visual prognosis compared to most patients with USH1.[healio.com]
  • The prognosis is optimistic, as most patients retain reading vision throughout life ( Felbor et al., 1997 ; Yamaguchi et al., 2001 ).For a discussion of genetic heterogeneity of vitelliform macular dystrophy, see VMD1 ( OMIM ).[mendelian.co]
  • Although N48K mutation testing will be an excellent diagnostic tool for USH3 in Ashkenazi Jews, it will be less useful for predicting clinical prognosis due to the highly variable expressivity that we observed.[jmg.bmj.com]

Etiology

  • Anderson Springer Science & Business Media, 2012/12/06 - 467 ページ The topics in this volume explore the etiology, cellular mechanisms, epidemiology, genetics, models and potential therapeutic measures for the blinding diseases of retinitis pigmentosa and[books.google.com]
  • Etiology So far, mutations in five genes ( MYO7A , USH1C , CDH23 , PCDH15 , USH1G ) and one locus ( USH1E ) have been implicated in US type 1.[orpha.net]
  • Study of the Etiology of Deafness in an Institutionalized Population in Colombia. Am J Med Genet. 1992;44:405-8. 4. Tamayo ML, Bernal JE, Tamayo GE, Frias JL, Alvira G, Vergara O, et al. Usher syndrome: results of a screening program in Colombia.[revistamedicina.net]
  • For the patients with residual hearing, newly developed cochlear implantation; EAS (Electric Acoustic Stimulation) is a good therapeutic option and therefore much attention should be paid to the etiology when considering individual intervention, i.e.,[journals.plos.org]

Epidemiology

  • Authored by 60 internationally recognized researchers, the book describes the normal development of the ear, updates the classification and epidemiology of hearing loss, and surveys the usage of audiometric tests and diagnostic medical examinations.[books.google.com]
Sex distribution
Age distribution

Pathophysiology

  • Comprehensively updated to reflect everything you need to know regarding retinal diagnosis, treatment, development, structure, function, and pathophysiology, this monumental ophthalmology reference work equips you with expert answers to virtually any[books.google.com]

Prevention

  • Prevention - Usher syndrome- type 1D Not supplied. Diagnosis - Usher syndrome- type 1D The signs and symptom information on this page attempts to provide a list of some possible signs and symptoms of Usher syndrome, type 1D.[checkorphan.org]
  • […] interactome appears to be important for hair cell development in the ear but its role in the retina remains unclear.SummaryUnderstanding clinical disease progression and molecular pathways is important in the progress towards developing gene therapy to prevent[discovery.ucl.ac.uk]
  • […] devices or cochlear implants [ 9 ] (which appear to enhance the quality of life) [ 10 ] Orientation and mobility training Communication services and independent living training that may include learning Braille, low vision services, or auditory training Prevention[patient.info]
  • Most of these mutations disrupt protein production, resulting in an abnormally small, nonfunctional version of cadherin 23 or preventing the production of any of this protein. Less frequently, mutations change single amino acids in cadherin 23.[ghr.nlm.nih.gov]
  • Other cataracts can make the entire lens cloudy and prevent the lens from focusing images into the eye.[retinafoundation.org]

Ask Question

5000 Characters left Format the text using: # Heading, **bold**, _italic_. HTML code is not allowed.
By publishing this question you agree to the TOS and Privacy policy.
• Use a precise title for your question.
• Ask a specific question and provide age, sex, symptoms, type and duration of treatment.
• Respect your own and other people's privacy, never post full names or contact information.
• Inappropriate questions will be deleted.
• In urgent cases contact a physician, visit a hospital or call an emergency service!